Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
150K
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
104K
-
Shares change
-
-13.2K
-
Total reported value, excl. options
-
$2.64M
-
Value change
-
-$327K
-
Number of buys
-
1
-
Number of sells
-
-3
-
Price
-
$25.40
Significant Holders of iShares Neuroscience and Healthcare ETF - Common Stock (IBRN) as of Q4 2024
5 filings reported holding IBRN - iShares Neuroscience and Healthcare ETF - Common Stock as of Q4 2024.
iShares Neuroscience and Healthcare ETF - Common Stock (IBRN) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 104K shares
of 150K outstanding shares and own 69.19% of the company stock.
Largest 5 shareholders include BlackRock, Inc. (103K shares), PRINCIPAL SECURITIES, INC. (732 shares), BANK OF MONTREAL /CAN/ (0 shares), FLOW TRADERS U.S. LLC (0 shares), and JANE STREET GROUP, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.